Effects of Lifelong Physical Activity on Aging and Immune Function
Immunometabolic and Neuromuscular Markers of Vitality Capacity : SENIOR Protocol
NA · Centre Hospitalier Universitaire de Nice · NCT06692543
This study is testing how staying active for a lifetime affects health and immune function in older adults over 55.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 55 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de Nice (other) |
| Locations | 1 site (Nice) |
| Trial ID | NCT06692543 on ClinicalTrials.gov |
What this trial studies
This study investigates how lifelong physical activity influences vitality capacity in older adults, focusing on neuromuscular function, metabolism, and immune response. Forty healthy participants over the age of 55 will be divided into two groups: those who have maintained regular physical activity for the past 30 years and those who have not. The study aims to assess differences in vitality capacity, particularly examining the role of T cell metabolism in relation to physical activity history. Participants will undergo comprehensive testing to evaluate their physical and immune health.
Who should consider this trial
Good fit: Ideal candidates are healthy men and women over 55 years old, with a history of structured aerobic physical activity for at least 30 years.
Not a fit: Patients who are younger than 55 or those who have not engaged in regular physical activity for the past 30 years may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into how maintaining physical activity can enhance health and vitality in aging individuals.
How similar studies have performed: Previous studies have shown that regular physical activity positively impacts aging and immune function, suggesting this approach is supported by existing evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
* General Inclusion Criteria: * Men and women \> 55 years old * Participants who are non-smokers or have been weaned for more than 3 years * Menopausal women (confirmed for at least 6 months) * Participants affiliated to the social security system * Signature of informed consent * Inclusion Criteria for the active population: * Any person with structured aerobic physical activity (mainly involving cardiorespiratory function) on at least 3 days/week over the last 30 years without an interruption of more than 1 week in the 3 months preceding the study and without an interruption of more than 12 consecutive months over the last 30 years, as assessed by an interview conducted by an investigator specialising in physical activity; * have a level of physical activity that meets the recommendations for physical activity in terms of the duration and intensity of weekly cardiorespiratory effort (WHO, 2020; ANSES, 2016) according to the criteria assessed by the GPAQ: at least 150 to 300 minutes per week of moderate-intensity aerobic activity (e.g., 5 days of moderate intensity activity of at least 30 minutes/day) or at least 75 to 150 minutes of sustained intensity endurance activity (e.g., 3 days of sustained activity of 25 minutes/day); or an equivalent combination of moderate and sustained intensity activities throughout the week. * Inclusion criteria for the inactive population : * Any person who does not meet the criteria for inclusion in the 'active' population defined above; * Any person who has or has had a low physical intensity professional activity over the last 30 years: sedentary professional activity (work time generally spent in a seated position, such as office work) and/or a standing professional activity (work time spent standing or walking, without intense physical effort (e.g. shop assistant, hairdresser, caretaker, etc.). * Anyone who does not practise or has not practised sport, fitness or other physical leisure activities alone or under supervision over the last 30 years, or who practises or has practised, over the last 30 years, a sport, fitness or other physical leisure activity less than or equal to 2 days a week and for a weekly period not exceeding 75 minutes. * Anyone whose active mode of transport (cycling, walking) does not exceed an overall duration of 75 minutes per week, and whose consecutive time slots per journey are less than 10 minutes. * Non-inclusion Criteria: * Person suffering from a chronic illness * Anyone who has used performance-enhancing drugs * Anyone with a disability * Person on medication * Recent hospitalisation (within the last 6 months) * People with osteoarthritis. * Anyone who has had a cardiovascular event in the last 30 years (angina, heart attack) * People with a current clinical acute inflammatory condition. * People who have practised sport with known vascular complications. * Persons under guardianship or trusteeship * Exclusion Criteria: withdraw of consent
Where this trial is running
Nice
- CHU de Nice — Nice, France (RECRUITING)
Study contacts
- Principal investigator: Olivier GUERIN, MD — Centre Hospitalier Universitaire de Nice
- Study coordinator: Anne-Sophie Rousseau, PU
- Email: anne-sophie.rousseau@univ-cotedazur.fr
- Phone: 06,83,52,26,73
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Aging, immunity, aging, muscles, exercise, metabolism, physical activity